Published in Prev Med on May 01, 1984
Antineoplastic drug exposure in an ambulatory setting: a pilot study. Cancer Nurs (2015) 0.88
DEFENS - Drug Exposure Feedback and Education for Nurses' Safety: study protocol for a randomized controlled trial. Trials (2015) 0.82
Occupational medicine: surveillance of hospital personnel exposed to cytotoxic drugs. West J Med (1985) 0.75
The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology (1970) 2.19
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology (1970) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res (1991) 1.40
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Laryngeal cancer and occupational exposure to sulfuric acid. Am J Epidemiol (1984) 1.25
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J Exp Med (1972) 1.14
Trajectories of PTSD risk and resilience in World Trade Center responders: an 8-year prospective cohort study. Psychol Med (2013) 1.13
Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res (1987) 1.11
Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res (1989) 1.09
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
Chemotherapy for advanced sarcoma: therapeutic decisions and modalities. Semin Oncol (1997) 1.06
Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol (1999) 1.04
Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res (1985) 1.03
Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res (1989) 1.02
Combat and herbicide exposures in Vietnam among a sample of American Legionnaires. Environ Res (1988) 1.00
The consistency of combat exposure reporting and course of PTSD in Vietnam War veterans. J Trauma Stress (2007) 1.00
Hematologic and immunologic aspects of parabiosis. Mt Sinai J Med (1976) 0.94
The impact of medicare funding on the use of mammography among older women: implications for improving access to screening. Prev Med (2000) 0.93
Occupational health hazards of women: an overview. Prev Med (1978) 0.92
Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors. Oncogene (2006) 0.91
Letter: Lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1975) 0.91
Estimation of exposure to Agent Orange and other defoliants among American troops in Vietnam: a methodological approach. Am J Ind Med (1986) 0.91
Health and reproductive outcomes among American Legionnaires in relation to combat and herbicide exposure in Vietnam. Environ Res (1988) 0.90
Immunologic diagnosis and monitoring of human acute leukemias: a review. Am J Pathol (1981) 0.90
Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva. Trans Am Ophthalmol Soc (1976) 0.89
Specific impairment of humoral and cellular allograft immunity after splenic allotransplantation in rats. Transplant Proc (1977) 0.88
Immunotherapy of human cancer. Prog Allergy (1973) 0.87
Specificity of heteroantisera to human acute leukemia-associated antigens. J Clin Invest (1974) 0.87
Immunologic aberrations in the Di Guglielmo syndrome. Blood (1966) 0.87
Induction of granulomas in mice by inoculation of tissue homogenates from patients with inflammatory bowel disease and sarcoidosis. Ann N Y Acad Sci (1976) 0.86
Post-traumatic stress disorder among American Legionnaires in relation to combat experience in Vietnam: associated and contributing factors. Environ Res (1988) 0.86
Isolation and partial characterization of radioiodinated myeloblastic leukemia-associated cell surface glycoprotein antigen. Cancer Res (1978) 0.85
Transmission of ileitis and sarcoid granulomas to mice. Trans Assoc Am Physicians (1974) 0.85
Delayed cutaneous hypersensitivity in leukaemic patients to autologous blast cells. Br J Haematol (1974) 0.84
Prolongation of skin homograft survival by mouse-anti-mouse thymocyte isoantiserum. Transplant Proc (1969) 0.84
Effects of heterologous antilymphocyte serum on lymphoid cells labeled with 5-iodo-2-deoxyuridine-125-I. Fed Proc (1970) 0.84
Characterization of compounds shed from the surface of human leukemic myeloblasts in vitro. Blood (1982) 0.84
Editorial: A transmissible agent in Crohn's disease? New pursuit of an old concept. N Engl J Med (1975) 0.84
Cyclophosphamide-induced immunologic tolerance to skin homografts. Surg Forum (1971) 0.84
Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells. Cancer Res (1985) 0.83
Serologic characterization of a monkey antiserum to human leukemic myeloblasts. Blood (1980) 0.83
Peripheral blood lymphocyte subpopulations in sarcoidosis. Cell Immunol (1975) 0.83
Masking of neutrophil surface lectin-binding sites in chronic myelogenous leukemia (CML). Blood (1980) 0.83
Non-invasive magnetopneumographic determination of lung dust loads in steel arc welders. Br J Ind Med (1981) 0.83
Mechanisms and kinetics of cyclophosphamide-induced specific tolerance to skin allografts in mice. Transplant Proc (1973) 0.82
Antigen-induced immunological tolerance in man to equine anti-human-thymocyte gamma-globulin. Lancet (1969) 0.82
Effect of thymus enclosed in millipore diffusion envelopes on thymectomized hamsters. Blood (1966) 0.81
In vivo effects of concanavalin A. I. Immunosuppressive effects. Transplantation (1972) 0.81
Air quality and ergonomics in the office: survey results and methodologic issues. Am Ind Hyg Assoc J (1985) 0.81
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81
Cancer chemotherapeutic agents as occupational hazards: a literature review. Cancer Invest (1986) 0.81
Transpulmonary water exchange in newborn lambs under artificial placentation. Am J Physiol (1966) 0.80
Changes in the granulocyte membrane following chemotherapy for chronic myelogenous leukaemia. Br J Haematol (1986) 0.80
The goal: safety and equality. Am J Ind Med (1992) 0.80
Effects of concanavalin A on the migration of radioactively labeled lymphoid cells. Cell Immunol (1974) 0.80
Letter: B lymphocytes in inflammatory bowel disease. Lancet (1974) 0.79
Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials. Eur J Surg Oncol (2010) 0.79
Increased activity of a specific sialyltransferase in chronic myelogenous leukemia. Blood (1985) 0.79
Safety in the health care industry. Occup Health Nurs (1982) 0.78
Monosaccharide inhibition of E-rosette formation. Clin Immunol Immunopathol (1980) 0.78
Membrane glycoprotein changes associated with anthracycline resistance in HL-60 cells. Cancer Chemother Pharmacol (1991) 0.78
Platelets--cyclophosphamide-induced immunological tolerance to skin allografts in mice. Transplantation (1974) 0.78
Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients. Cancer Treat Rep (1983) 0.78
Women's occupations, smoking, and cancer and other diseases. CA Cancer J Clin (1981) 0.78
Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis. Cancer Res (1980) 0.77
Occupational bladder cancer. Lancet (1977) 0.77
Production of antiserum in mice to human leukaemia-associated antigens. Nat New Biol (1973) 0.77
Treatment of metastatic malignant melanoma with pimozide. Lancet (1979) 0.76
Effects of dopamine agonists and antagonists on murine melanoma: correlation with dopamine binding activity. Cancer (1982) 0.76
Aberrant sialylation of granulocyte membranes in chronic myelogenous leukemia. Blood (1984) 0.76
Antibody responses to leukemia-associated antigens during immunotherapy of chronic myelocytic leukemia. Blood (1975) 0.76
Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy. Cancer Res (1983) 0.76
B.C.G. in malignant melanoma. Lancet (1973) 0.75
Immunotherapy of human acute leukemia: antibody response to leukemia-associated antigens. Blood (1978) 0.75
Immunotherapy for chronic myelogenous leukemia: survival not affected by treatment in the stable phase. Cancer Res (1984) 0.75
Platelet-induced tolerance in the production of heteroantisera to human leukemia-associated antigens. J Immunol Methods (1976) 0.75
Early diagnosis of relapse in acute myeloblastic leukemia: Serologic detection of leukemia-associated antigens in human marrow. N Engl J Med (1979) 0.75
Microsurgical renal transplantation techniques in small animals. Invest Urol (1977) 0.75
Prolonged survival of skin allografts from uremic mice. Transplantation (1974) 0.75
The reading retreat: a new format for continuing medical education. Prog Clin Biol Res (1981) 0.75
Paradoxical effect of operative ischemia time on rat renal allograft survival. Surg Forum (1974) 0.75
Human acute myelogenous leukemia-associated antigens defined by a monkey antiserum to glycoproteins shed from leukemia myeloblasts. Leuk Res (1981) 0.75
Adjuvant immunotherapy for vulvar malignant melanoma. Mt Sinai J Med (1979) 0.75
Influence of cell surface galactosyl determinants on splenic localization of mouse thymocytes. Transplantation (1980) 0.75
Treatment of anthracycline extravasation--a warning against the use of sodium bicarbonate. J Clin Oncol (1987) 0.75
Human leukemic myeloblasts and myeloblastoid cells contain the enzyme cytidine 5'-monophosphate-N-acetylneuraminic acid:Gal beta 1-3GalNAc alpha (2-3)-sialyltransferase. Cancer Res (1990) 0.75
The kinetic behaviour of transfused donor bone marrow neutrophils and their precursors in neutropenic patients. Br J Haematol (1973) 0.75
Homogeneously staining region in anthracycline-resistant HL-60/AR cells not associated with MDR1 amplification. Cancer Res (1992) 0.75
Acute myeloblastic leukemia-associated antigens: detection and clinical importance. Haematol Blood Transfus (1981) 0.75